Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program

  • Lukas Richter,
  • Daniela Schmid,
  • Elisabeth Eva Kanitz,
  • Ines Zwazl,
  • Eva Pöllabauer,
  • Joanna Jasinska,
  • Heinz Burgmann,
  • Michael Kundi,
  • Ursula Wiedermann

There are errors in S1 Table and S2 Table. Column name “VE (95%CI)” in S1 Table should be “VE in % (95%CI).” Column name “reference pre-period IR” in S2 Table should be “reference pre-period IR/106.”

thumbnail
Download:
S1 Table. Vaccine effectiveness of the childhood 2+1 PCV10 program among <5, and the age-subgroup <2 years, estimated by pre-post rate comparison, and among the ≥50 and age-subgroup ≥60 years, estimated by the segmented time series regression analysis, Austria, January, 2009-February, 2017.

https://doi.org/10.1371/journal.pone.0212957.t001

thumbnail
Download:
S2 Table. Serotype-specific analyses: monthly average incidence rate of the pre-period (pre-period IR as reference), pre-early post and pre-late post IR ratios with 95% confidence interval (CI) of the top 10 serotypes of the pre-period among <5 and ≥50 years old, Austria, January, 2009-February, 2017.

https://doi.org/10.1371/journal.pone.0212957.t002

Reference

  1. 1. Richter L, Schmid D, Kanitz EE, Zwazl I, Pöllabauer E, Jasinska J, et al. (2019) Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program. PLoS ONE 14(1): e0210081. https://doi.org/10.1371/journal.pone.0210081 pmid:30629620

Citation: Richter L, Schmid D, Kanitz EE, Zwazl I, Pöllabauer E, Jasinska J, et al. (2019) Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program. PLoS ONE 14(2): e0212957. https://doi.org/10.1371/journal.pone.0212957

Published: February 21, 2019

Copyright: © 2019 Richter et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.